What does Elevar Equity invest in?
Elevar Equity invests most often at Series C and Seed (78% of the rounds on record), in sectors such as Biotechnology and Nanotechnology.
United States · Investor
Last cheque observed Oct 2026; 12 cheques on record.
Deploying nowVC firm
2 cheques in the last 12 months
Mostly Series C and Seed: 78% of its rounds
Sole investor in 4 rounds, median $6.1M
Every round we can evidence, newest first12 appearances
2 rounds
2 rounds
2 rounds
1 round
1 round
2 rounds
2 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
We hold 2 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
The latest companies Elevar Equity put money into.
Elevar Equity invests most often at Series C and Seed (78% of the rounds on record), in sectors such as Biotechnology and Nanotechnology.
12 investments on record, 2 of them in the last 12 months, and it led 6. The most recent was in Oct 2026.
Its most recent investments on record: CureBay (Series C, Oct 2026), byteXL (Oct 2026) and TapFin (Seed, Mar 2024).
The median round it joins is $6.8M.
Yes: it led 6 of its 12 investments on record (50%).
Most of the companies it backs are in India (92%) and Mexico (8%).
Yes: it is actively investing, with 2 investments in the last 12 months.
Elevar Equity is a VC firm based in United States.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it